HLNE Hamilton Lane Inc

Copeland Capital Management LLC reduced its stake in Hamilton Lane Inc. (NASDAQ:HLNE) by 5.0% in Q3, selling 25,851 shares and now holding 495,185 shares valued at $66.7 million. Hamilton Lane exceeded quarterly expectations with EPS of $1.54 and revenue of $190.9 million, also declaring a quarterly dividend of $0.54. Insider activity shows CEO Juan Delgado-Moreira recently purchased 8,000 shares, and institutional investors own 97.40% of the company's stock.

Harbor Capital Advisors Inc. significantly reduced its stake in Hamilton Lane Inc. (NASDAQ:HLNE) by 71.2% in the third quarter of 2025, selling 8,400 shares and retaining 3,394 shares valued at $457,000. Despite this institutional reduction, Hamilton Lane's CEO, Juan Delgado-Moreira, recently increased his personal holdings by purchasing 8,000 shares, bringing insider ownership to over 22%. Analyst sentiment remains moderately positive with a consensus "Moderate Buy" rating and an average price target of $160.50.

Orion Portfolio Solutions LLC significantly reduced its stake in Hamilton Lane Inc. (NASDAQ:HLNE) by 62.7% during the second quarter, selling 11,595 shares. Despite this, other major institutional investors like Champlain Investment Partners, Raymond James Financial Inc., and Norges Bank increased their holdings, leading to institutional ownership of approximately 97.4%. Hamilton Lane consistently outperforms earnings estimates and offers a quarterly dividend, maintaining a "Moderate Buy" consensus rating from Wall Street analysts with a target price of $160.50.

Hamilton Lane Advisors LLC has acquired a new position in Hims & Hers Health, Inc. (NYSE:HIMS), purchasing 33,985 shares valued at approximately $1.93 million, making it 1.1% of the fund’s holdings. This comes as the company's board authorized a $250 million stock buyback program, suggesting management believes the shares are undervalued, despite recent insider selling activity totalling over $10 million.

Invesco Ltd. has reduced its stake in Hamilton Lane Inc. by 21.7% in Q2, selling 395,975 shares but still holding 1,429,859 shares valued at over $203 million. CEO Juan Delgado-Moreira increased his personal holdings by acquiring 8,000 shares, bringing insider ownership to 22.21%. Hamilton Lane also surpassed Q2 earnings and revenue estimates and announced a quarterly dividend of $0.54 per share.

Hamilton Lane Incorporated (NASDAQ:HLNE) currently trades at a P/E ratio of 24.1x, which is higher than the market average of 18x, despite its earnings growth being less attractive than the broader market's forecast. While the company achieved a 19% gain in its bottom line over the last year and EPS lifted 39% in aggregate over three years, its annualized growth falls short of the market's 16% one-year forecast. This suggests that investors might be overlooking the company's relatively limited recent growth rates, potentially setting themselves up for disappointment if the P/E ratio adjusts to align with actual growth.